Statistics for Xenon Pharmaceuticals Inc (id:6426 XENE)

Valuation metrics

Market cap

3.04B

Enterprise value

2.47B

Trailing P/E (ttm)

-15.07

Forward P/E

-11.19

PEG ratio

-11.19

Price/Sales (ttm)

Price/Book (mrq)

3.24

Enterprise Value/Revenue

Enterprise Value/EBITDA

-10.56

Overview

Shares outstanding

76.24M

Float

69.99M

Shares short

2.89M

% Held by insiders

0.00%

% Held by institutions

1.01%

Average volume (10 days)

404.17K

Average volume (90 days)

Price summary

52-Week low

28.20

52-Week high

50.99

52-Week change

29.60%

Beta

1.25

50-Day moving average

41.20

200-Day moving average

41.68

Dividends and splits

Forward annual dividend rate

Forward annual dividend yield

Trailing annual dividend rate

0.00%

Trailing annual dividend yield

0.00

5-Year annual dividend yield

Payout ratio

0.00

Dividend date

Ex-dividend date

Last split factor

2:1

Last split date

Financials

Fiscal year

Fiscal year ends

December 31th, 2023

Most recent quarter (mrq)

June 30th, 2024

Profitability

Profit margin

0.00%

Operating margin

0.00%

Operational effectiveness

Return on assets

-18.92%

Return on equity

-26.71%

Income statement

Revenue (ttm)

0.00

Revenue per share (ttm)

0.00

Quarterly revenue growth (yoy)

Gross profit (ttm)

0.00

EBITDA

-233,680,992.00

Net income to common (ttm)

-199,060,000.00

Diluted EPS (ttm)

-2.81

Quarterly earnings growth (yoy)

Balance sheet

Total cash (mrq)

721.53M

Total cash per share (mrq)

9.52

Total debt (mrq)

10.03M

Total Debt/Equity (mrq)

1.19

Current ratio (mrq)

2.33K%

Book value per share (mrq)

12.31

Cash flow

Cash flow statement

-153,552,000.00

Levered free cash flow (LFCF)

-104,091,504.00